Evaluation of Pathogenic Variants Associated With Monogenic Disorders of Dyslipidemia in Patients With Well Characterised <scp>MASLD</scp>
Monogenic disorders of dyslipidemia are rarely present in patients with MASLD and are sometimes associated with worse liver histology. Testing for these conditions may be considered on a case-by-case basis.
Authors
- Luca Lotta (ORCID: https://orcid.org/0000-0003-4592-1535)
- Brent A. Neuschwander‐Tetri (ORCID: https://orcid.org/0000-0002-8520-7398)
- J Wang
- Katherine P. Yates (ORCID: https://orcid.org/0000-0001-6138-2194)
- Marco A. Abreu
- RA Hegele
- Xiuqing Guo
- Niek Verweij
- Jingyi Tan (ORCID: https://orcid.org/0000-0003-4207-6516)
- Nicholas O. Davidson
- Naga Chalasani
- Jerome I. Rotter
- Tae‐Hwi Schwantes‐An
Institutions
- Western University (CA)
- Johns Hopkins University (US)
- Regeneron (United States) (US)
- Washington University in St. Louis (US)
- Johns Hopkins Medicine (US)
- UCLA Medical Center (US)
- Los Angeles Biomedical Research Institute (US)
- Indiana University School of Medicine
- Saint Louis University (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Liver International
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1111/liv.70486
- Primary Topic
- Lipid metabolism and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Takeda Pharmaceuticals North America
- Pharmavite
- Intercept Pharmaceuticals
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases